HIRONIC CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,200 KRW | 0.00% |
|
+2.24% | +5.47% |
| 2021 | Hironic Co., Ltd. announced that it has received KRW 3 billion in funding | CI |
| 2021 | Hironic Co., Ltd. announced that it expects to receive KRW 3 billion in funding | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | 27.57B 20.18M | Sales 2023 | 33.73B 24.69M | Capitalization | 127B 92.68M |
|---|---|---|---|---|---|
| Net income 2022 | 2.93B 2.15M | Net income 2023 | 8.22B 6.02M | EV / Sales 2022 | 3.05 x |
| Net cash position 2022 | 21.12B 15.46M | Net cash position 2023 | 20.79B 15.22M | EV / Sales 2023 | 3.14 x |
| P/E ratio 2022 |
36.9
x | P/E ratio 2023 |
16
x | Employees | 90 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 42.92% |
More Fundamentals
* Assessed data
More news
| 1 week | +2.24% | ||
| Current month | +2.24% | ||
| 1 month | +1.49% | ||
| 3 months | +0.99% | ||
| 6 months | +8.13% | ||
| Current year | +5.47% |
1 week
8 060.00
8 520.00
1 month
7 650.008 520.00
Current year
6 830.009 940.00
1 year
5 366.6711 616.67
3 years
3 435.6111 616.67
5 years
1 575.7611 616.67
10 years
1 575.7623 439.39
| Managers | Title | Age | Since |
|---|---|---|---|
Seok-Kwang Park
CEO | Chief Executive Officer | 63 | - |
Jin-Woo Lee
CHM | Chairman | 49 | 09-09-30 |
Seung-Noh Joo
AUD | Comptroller/Controller/Auditor | 68 | 15-03-25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jin-Woo Lee
CHM | Chairman | 49 | 09-09-30 |
Seok-Kwang Park
CEO | Chief Executive Officer | 63 | - |
Eun-Sook Lee
FOU | Founder | 50 | 07-12-10 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-08 | 8,200 | 0.00% | 146,480 |
| 24-05-07 | 8,200 | -1.56% | 131,769 |
| 24-05-03 | 8,330 | +1.22% | 534,330 |
| 24-05-02 | 8,230 | +2.62% | 184,705 |
| 24-04-30 | 8,020 | +0.25% | 93,924 |
End-of-day quote Korea S.E., May 07, 2024
More quotes
Hironic Co., Ltd is a Korea-based company mainly engaged in the research and development, manufacture and distribution of medical equipment for skin care. The Company mainly manufactures medical equipment for skin and obesity care or treatment. The Companyâs products include MIXEL, a skin cure equipment for skin lesions and melasma, as well as improving skin texture and tone; MIPL, a skin treatment equipment for pigmentation, wrinkle, vascular, acne and hair removal; MIDEPI, a hair removal equipment; DOUBLO, which is skin treatment equipment for skin tightening and rejuvenation, non-invasive lifting for face and eyebrow lifting; MICOOL, a treatment equipment of natural fat cell destruction, and New Midas, which is used for body contouring and face lifting.
Calendar
2024-05-12
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +5.47% | 98.94M | |
| +8.10% | 219B | |
| +8.00% | 185B | |
| +13.24% | 135B | |
| +27.19% | 107B | |
| +12.96% | 51.28B | |
| +4.88% | 51.01B | |
| +3.17% | 41.85B | |
| +5.98% | 37.02B | |
| +24.38% | 31.27B |
- Stock Market
- Equities
- A149980 Stock